The side effects associated with the HIV drug Abacavir have once again come into question as researchers announce contradictory findings.
In January this year it was announced Abacavir, a widely used nucleoside reverse transcriptase inhibitor, potentially increased a patient’s risk of heart disease by 90 percent.
These findings have come under scrutiny once more, after it was announced at the Mexico AIDS conference that any such increased risks mainly pertained to people with an already heightened risk of heart disease.
http://www.starobserver.com.au/news/2008/08/20/abacavir-findings-still-inconclusive/1277